Quan DH - Search Results

1

Synergistic oral beta-lactam combinations for treating tuberculosis.

Quan DH, Wang T, Martinez E, Kim HY, Sintchenko V, Britton WJ, Triccas JA, Alffenaar JC. Quan DH, et al. J Appl Microbiol. 2024 Oct 3;135(10):lxae255. doi: 10.1093/jambio/lxae255. J Appl Microbiol. 2024. PMID: 39394664

2

In Vitro Evaluation of Inhalable Verapamil-Rifapentine Particles for Tuberculosis Therapy.

Parumasivam T, Chan JG, Pang A, Quan DH, Triccas JA, Britton WJ, Chan HK. Parumasivam T, et al. Among authors: quan dh. Mol Pharm. 2016 Mar 7;13(3):979-89. doi: 10.1021/acs.molpharmaceut.5b00833. Epub 2016 Feb 12. Mol Pharm. 2016. PMID: 26808409

3

In vitro evaluation of novel inhalable dry powders consisting of thioridazine and rifapentine for rapid tuberculosis treatment.

Parumasivam T, Chan JG, Pang A, Quan DH, Triccas JA, Britton WJ, Chan HK. Parumasivam T, et al. Among authors: quan dh. Eur J Pharm Biopharm. 2016 Oct;107:205-14. doi: 10.1016/j.ejpb.2016.07.014. Epub 2016 Jul 12. Eur J Pharm Biopharm. 2016. PMID: 27422209

4

New tuberculosis drug leads from naturally occurring compounds.

Quan D, Nagalingam G, Payne R, Triccas JA. Quan D, et al. Int J Infect Dis. 2017 Mar;56:212-220. doi: 10.1016/j.ijid.2016.12.024. Epub 2017 Jan 3. Int J Infect Dis. 2017. PMID: 28062229 Free article. Review.

5

Bengamides display potent activity against drug-resistant Mycobacterium tuberculosis.

Quan DH, Nagalingam G, Luck I, Proschogo N, Pillalamarri V, Addlagatta A, Martinez E, Sintchenko V, Rutledge PJ, Triccas JA. Quan DH, et al. Sci Rep. 2019 Oct 7;9(1):14396. doi: 10.1038/s41598-019-50748-2. Sci Rep. 2019. PMID: 31591407 Free PMC article.

6

Lung IL-17A-Producing CD4⁺ T Cells Correlate with Protection after Intrapulmonary Vaccination with Differentially Adjuvanted Tuberculosis Vaccines.

Stewart EL, Counoupas C, Quan DH, Wang T, Petrovsky N, Britton WJ, Triccas JA. Stewart EL, et al. Among authors: quan dh. Vaccines (Basel). 2024 Jan 26;12(2):128. doi: 10.3390/vaccines12020128. Vaccines (Basel). 2024. PMID: 38400112 Free PMC article.

7

Advax adjuvant formulations promote protective immunity against aerosol Mycobacterium tuberculosis in the absence of deleterious inflammation and reactogenicity.

Quan DH, Counoupas C, Nagalingam G, Pinto R, Petrovsky N, Britton WJ, Triccas JA. Quan DH, et al. Vaccine. 2021 Apr 1;39(14):1990-1996. doi: 10.1016/j.vaccine.2021.02.041. Epub 2021 Mar 11. Vaccine. 2021. PMID: 33714652

8

No smoke without fire: the impact of cigarette smoking on the immune control of tuberculosis.

Quan DH, Kwong AJ, Hansbro PM, Britton WJ. Quan DH, et al. Eur Respir Rev. 2022 Jun 7;31(164):210252. doi: 10.1183/16000617.0252-2021. Print 2022 Jun 30. Eur Respir Rev. 2022. PMID: 35675921 Free PMC article. Review.

9

Carborane clusters increase the potency of bis-substituted cyclam derivatives against Mycobacterium tuberculosis.

Smith N, Quan D, Nagalingam G, Triccas JA, Rendina LM, Rutledge PJ. Smith N, et al. RSC Med Chem. 2022 Aug 2;13(10):1234-1238. doi: 10.1039/d2md00150k. eCollection 2022 Oct 19. RSC Med Chem. 2022. PMID: 36325397 Free PMC article.

10

CXCR3 Provides a Competitive Advantage for Retention of Mycobacterium tuberculosis-Specific Tissue-Resident Memory T Cells Following a Mucosal Tuberculosis Vaccine.

Armitage E, Quan D, Flórido M, Palendira U, Triccas JA, Britton WJ. Armitage E, et al. Vaccines (Basel). 2023 Sep 29;11(10):1549. doi: 10.3390/vaccines11101549. Vaccines (Basel). 2023. PMID: 37896952 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters